CIDP (chronic inflammatory demyelinating polyneuropathy) trials in Germany
7 of 17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleReal-World Efgartigimod Effectiveness in CIDP: A Prospective Study
- Where
- Berlin, Bochum, Cologne, Düsseldorf, Frankfurt, Giessen, Göttingen, Hamburg, Hanover, Homburg, Magdeburg, Mannheim, Marburg, Minden, München, Potsdam, Rüdersdorf, Schwäbisch Hall, Tübingen, Ulm
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- argenx
See details and how to joinNCT07264426 - No phaseTaking peopleMultimodal Characterization of Movement Trajectories in Chronic Inflammatory Demyelinating Polyneuropathy
- Where
- Düsseldorf
- Age
- 18 years and over
- People
- 50
- Run by
- Heinrich-Heine University, Duesseldorf
See details and how to joinNCT07882797 - No phaseTaking peopleSubcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices
- Where
- Düsseldorf, Münster
- Age
- 18 years and over
- People
- 35
- Run by
- Heinrich-Heine University, Duesseldorf
See details and how to joinNCT07273903 - No phaseTaking peopleA Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- Where
- Bochum
- People
- 279 worldwide
- Run by
- argenx
See details and how to joinNCT06299748 - No phaseTaking peopleA Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
- Where
- Berlin, Bochum, Marburg, Rüdersdorf
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- Takeda
See details and how to joinNCT06538064 · EU 2024-512690-26-00 - No phaseTaking peopleImmunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Ulm
- Age
- 18 years and over
- People
- 140
- Run by
- University of Ulm
See details and how to joinNCT07154524 - No phaseEnrolling by invitationDevelopment and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders
- Where
- München
- Age
- 18 years to 65 years
- People
- 108
- Run by
- LMU Klinikum
See details and how to joinNCT06605612